Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A startup is developing the first vaccine to target patients before they develop cancer.
Immune therapy proves effective against melanoma in an early trial.
A chemical “staple” creates mobile biological molecules with staying power.
The largest cancer genome sequencing project yet highlights molecular pathways at the heart of an aggressive blood cancer.
Repetitive stretches of RNA are found in high concentrations in cancer cells.
Tumors can evolve resistance to powerful new cancer drugs. But scientists are now learning why, giving hints at how to stop it.
The devices may one day help patients skip invasive and painful biopsies.
Researchers call the experimental drug a major success for targeted cancer therapies.
Drug companies are harnessing new knowledge of cancer genetics.